IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Sophiris Bio, Inc.
Symbol: SPHS
Price: Last trade $5.82
Description: No re-offer range available
Trade Date: 8/23
Shares: 4.3 million
Underwriter(s) Piper Jaffray
Rating=Subscription Needed
Secondaries announced 08.22.2016